522
Views
11
CrossRef citations to date
0
Altmetric
Original

LEFT VENTRICULAR HYPERTROPHY IS A RISK FACTOR INDEPENDENT OF HYPERTENSION IN SURVIVAL OF HEMODIALYZED PATIENTS

, M.D., , , &
Pages 175-186 | Published online: 07 Jul 2009

REFERENCES

  • Maeda K. For Statistical Survey Committee: An Overview of Dialysis Treatment in Japan (as of Dec. 31, 1996). J. Jpn. Soc. Dial. Ther. 1998; 31: 1–24
  • United States Renal Data System. USRDS 1997 Annual Data Report U.S. Department of Health and Human Service. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 1997, August
  • Harnett J.D., Kent G.M., Foley R.N., Parfrey P.S. Cardiac Function and Hematocrit Level. Am J. Kidney Dis. 1995; 25: S3–S7
  • Harnett J.D., Parfrey P.S. Left Ventricular Dysfunction in Dialysis Subjects. Principles and Practice of Dialysis, W.L. Henrich. Williams & Wilkins, Baltimore 1994; 170–180
  • Kannel W.B., Gordon T., Offutt D. Left Ventricular Hypertrophy by Electrocardiogram. Prevalence, Incidence, and Mortality in the Framingham Study. Ann. Int. Med. 1969; 71: 89–105
  • Casale P.N., Devereux R.B., Milner M., Zullo G., Harshfield A., Pickering T.G., Laragh J.H. Value of Echocardiographic Measurement of Left Ventricular Mass in Predicting Cardiovascular Morbid Events in Hypertensive Men. Ann. Int. Med. 1986; 105: 173–178
  • Levy D., Savage D.D., Garrison R.J., Anderson K.M., Kannel W.B., Castelli W.P. Echocardiographic Criteria for Left Ventricular Hypertrophy: The Framingham Heart Study. Am. J. Cardiol. 1987; 59: 956–960
  • Tomita J., Kimura G., Inoue T., Inenaga T., Sanai T., Kawano Y., Nakamura S., Baba S., Matsuoka H., Omae T. Role of Systolic Blood Pressure in Determining Prognosis of Hemodialyzed Patients. Am. J. Kidney Dis. 1995; 25: 405–412
  • Kimura G., Tomita J., Nakamura S., Uzu T., Inenaga T. Interaction Between Hypertension and Other Cardiovascular Risk Factors in Survival of Hemodialyzed Patients. Am. J. Hypertens. 1996; 9: 1006–1012
  • Kannel W.B. Framingham Study Insights into Hypertensive Risk of Cardiovascular Disease. Hypertens. Res. 1996; 18: 181–196
  • Reichek N., Devereux R.B. Left Ventricular Hypertrophy: Relationship of Anatomic, Echocardiographic and Electrocardiographic Findings. Circulation 1981; 63: 1391–1398
  • Devereux R.B., Alonso D.R., Lutas E.M., Gottlieb G.J., Campo E., Sachs I., Reichek N. Echocardiographic Assessment of Left Ventricular Hypertrophy: Comparison to Necropsy Findings. Am. J. Cardiol. 1986; 57: 450–458
  • Chikos P.M., Figrey M.M., Fisher A.L. Correlation Between Chest Film and Angiographic Assessment of Left Ventricular Size. Am. J. Roentgenol. 1977; 128: 367–373
  • Foley R.N., Parfrey P.S. Cardiac Disease in Chronic Uremia: Clinical Outcome and Risk Factors. Adv. Ren. Replace Ther. 1997; 4: 234–248
  • Foley R.N., Parfrey P.S., Harnett J.D., Kent G.M., Martin C.J., Murray D.C., Barre P.E. Clinical and Echocardiographic Cardiovascular Disease in End Stage Renal Disease: Prevalence, Associations and Prognosis. Kidney Int. 1995; 47: 186–192
  • Harnett J.D., Murphy B., Collingwood P., Purchase L., Kent G.M., Parfrey P.S. The Reliability and Validity of Echocardiographic Measurement of Left Ventricular Mass Index in Hemodialysis Patients. Nephron. 1993; 71: 212–214
  • Silberberg J.S., Barre P.E., Prichard S.S., Sniderman A.D. Impact of Left Ventricular Hypertrophy on Survival in End-Stage Renal Disease. Kidney Int. 1989; 36: 286–290
  • Silberberg J.S., Rahal D.P., Patton R., Sniderman A.D. Role of Anemia in the Pathogenesis of Left Ventricular Hypertrophy in End-Stage Renal Disease. Am. J. Cardiol. 1989; 64: 222–224
  • Parfrey P.S., Harnett J.D., Griffiths S.M., Taylor R., Hand J., King A., Barre P.E. The Clinical Course of Left Ventricular Hypertrophy in Dialysis Patients. Nephron. 1990; 55: 114–120
  • Foley R.N., Parfrey P.S., Harnett J.D., Kent G.M., Murray D.C., Barre P.E. The Prognostic Importance of Left Ventricular Geometry in Uremic Cardiomyopathy. J. Am. Soc. Nephrol. 1995; 5: 2024–2031
  • Harnett J.D., Foley R.N., Kent G.M., Murray D.C., Barre P.E., Parfrey P.S. Congestive Heart Failure in Dialysis Patients: Prevalence, Incidence, Prognosis and Risk Factors. Kidney Int. 1995; 47: 884–890
  • Harnett J.D., Kent G.M., Barre P.E., Taylor R., Parfrey P.S. Risk Factors for the Development of Left Ventricular Hypertrophy in a Prospectively Followed Cohort of Dialysis Patients. J. Am. Soc. Nephrol. 1994; 4: 1486–1490
  • Silberberg J.S., Racine N., Barre P., Snidermann A. Regression of Left Ventricular Hypertrophy in Dialysis Patients Following Correction of Anemia with Recombinant Human Erythropoietin. Can. J. Cardiol. 1990; 6: 1–4
  • Stefenelli T., Mayr H., Bergler-Klein J., Globits S., Woloszczuk W., Niederle B. Primary Hyperparathyroidism; Incidence of Cardiac Abnormalities and Partial Reversibility After Successful Parathyroidectomy. Am. J. Med. 1993; 95: 197–202
  • London G.M., Fabiani F., Marchais S.J., De Vernejoul M.-C., Guerin A.P., Safer M.E., Metivier F. Uremic Cardiomyopathy: An Inadequate Left Ventricular Hypertrophy. Kidney Int. 1987; 31: 973–980
  • London G.M., De Vernejoul M.-C., Fabiani F., Marchais S.J., Guerin A.P., Metivier F., Chappuis P., Llach F. Association Between Aluminum Accumulation and Cardiac Hypertrophy in Hemodialyzed Patients. Am. J. Kidney Dis. 1989; 13: 75–83
  • Rambusek M., Amann K., Mall G., Ritz E. Structural Causes of Cardiac Dysfunction in Uremia. Renal Failure 1993; 15: 421–428
  • Weisenee D., Low-Friedrich I., Richle M., Bereiter-Hahn J., Schoeppe W. In Vitro Approach to Uremic Cardiomyopathy. Nephron. 1993; 65: 392–400
  • Weidmann P., Maxwell M.H. Hypertension. Clinical Aspects of Uremia and Dialysis, S.G. Massry, A.L. Sellers. Charles C. Thomas, Illinois 1976; 100–139
  • Campese V.M., Chervu I. Hypertension in Dialysis Subjects. Principles and Practice of Dialysis, W.L. Henrich. Williams & Wilkins, Bartimore 1994; 148–169
  • Cannella G., Paoletti E., Delfino R., Peloso G., Malinari S., Taverso G.B. Regression of Left Ventricular Hypertrophy in Hypertensive Dialyzed Patients on Long-Term Antihypertensive Therapy. Kidney Int. 1993; 44: 881–886
  • Zehnder C., Zuber M., Sulzer M., Meyer B., Straumann F., Jenzer H.R., Blumberg A. Influence of Long-Term Amelioration of Anemia and Blood Pressure on Left Ventricular Hypertrophy in Hemodialyzed Patients. Nephron. 1992; 64: 202–206
  • Wizemann V., Schaffer R., Kramer W. Follow-Up of Changes Induced by Anemia Compensation in Normotensive Hemodialysis Patients with Left Ventricular Hypertrophy. Nephron. 1993; 64: 202–206

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.